Volume 13, Number 1—January 2007
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
|Outcome evaluated||Discordant vs. concordant empiric antimicrobial drug therapy†|
|OR (95% CI)||p value|
|Length of stay, d||1.6 (0.4–6.5)||0.54|
|Intensive care unit length of stay, d||5.8 (1.2–27.1)||0.03|
|Mortality rate (%)||0.7 (0.1–4.5)||0.74|
*OR, odds ratio; CI, confidence interval.
†Model includes modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.
- Page created: June 28, 2010
- Page last updated: June 28, 2010
- Page last reviewed: June 28, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)